Russell P. Beyer
Chief Financial Officer, SAB Biotherapeutics, Inc.
Companies
- SAB Biotherapeutics, Inc.Chief financial officer Oct 22, 2021 to Mar 16, 20231
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- SAB Biotherapeutics, Inc. SABS2,475 shares2$6.4K at $2.60Oct 26, 2021
As of each latest filing. The line shows shares held over time.
Recent filings
- Oct 26, 2021Sold 278 shares at $7.90 of SAB Biotherapeutics, Inc.2
- Oct 25, 2021Granted 129 shares at $7.78 of SAB Biotherapeutics, Inc.2
- Oct 18, 2021Granted 2,475 shares at $10.10 of SAB Biotherapeutics, Inc.2
- Sep 29, 2021Granted 10 shares at $10.08 of SAB Biotherapeutics, Inc.2
- Sep 28, 2021Granted 5 shares at $10.07 of SAB Biotherapeutics, Inc.2
- Sep 28, 2021Granted 149 shares at $10.08 of SAB Biotherapeutics, Inc.2
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2